| Name | Title | Contact Details |
|---|
ProSomnus is the first manufacturer of precision, mass-customized Precision Oral Appliance Therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus`s patented devices are a more comfortable and less invasive alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to more effective and patient-preferred outcomes. With more than 150,000 patients treated, ProSomnus`s devices are the most prescribed Precision Oral Appliance Therapy in the U.S.
Saratoga Ventures LP is a Saratoga, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lombard Medical Technologies (LMT) develops, manufactures and markets stent grafts for the treatment of abdominal and thoracic aortic aneurysms, endovascular stapling devices for the fixation of stent grafts and percutaneous heart valves, and develops drug delivery coatings. The Company was established in July 2000 and currently employs over 100 people at Didcot, Sheffield and Ayrshire in the UK and in the USA. The Company also has trade investments in an emerging medical device company. Lombard Medical Technologies PLC is listed on the London Stock Exchange (AIM) under the symbol LMT.
GlobalMed Inc. is a Trenton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Companion Medical is a leader in the development of advanced technology to improve diabetes care. Companion`s InPen system is available in the U.S. and is the only FDA-cleared, smart insulin pen paired with an integrated diabetes management app.